Business Wire

EXPEREO

31.1.2024 09:01:28 CET | Business Wire | Press release

Share
Expereo launches Enhanced Internet, the world’s first AI driven & fully internet-based solution to improve application performance globally

Expereo, the intelligent internet company that connects people, places and things anywhere, today launched its Enhanced Internet service, the first and only AI-driven solution that continually monitors the 100,000 networks that make up the internet and predicts the best performing route for companies’ network traffic.

Empowering Cloud Performance

Despite large investments into Cloud first strategies and SaaS applications, many enterprises are still experiencing inconsistent network performance that impacts employees productivity and experience. Enhanced Internet tackles this issue by improving the consistency and quality of application performance and enables businesses to get the most from their investments in cloud and SaaS strategies.

Companies typically spend approximately €500 per employee per month on cloud based applications. Despite this investment, issues in application performance can arise when their network traffic is impacted by latency, jitter, and poor performing routes. This can have serious implications, such as a decline in employee productivity and poor user experience, which can significantly impact the company’s financial performance.

Leveraging AI and Machine Learning to Improve Efficiencies

Enhanced Internet’s AI capabilities means that customers can experience the agility and accessibility of the public internet, combined with the reliability and consistent performance levels typically expected from a private network or MPLS solution. Expereo’s proprietary AI software does this by combining AI with Machine-Learning to intelligently and proactively route network traffic over the best possible path. For customers, the knowledge extends to predictive routes for specific situation by learning the most common traffic paths for their applications and therefore being ready to predict the path before the traffic is sent.

What businesses now have at their disposal is a self-healing network that can navigate past latency and packet loss caused by network congestion.

Complete visibility from a single login.

Paired with Expereo’s customer experience platform expereoOne, businesses can have complete visibility of the health of their network and transparency showing how Enhanced Internet has improved their application performance all from a single login. In addition to performance data, incident management, order status and invoices at site level, expereoOne displays latency and packet loss statistics, percentage of times routes have been changed and overall quality of service statistics personalized by Top 5 cloud destinations for their business. Complete visibility of how application performance has been improved by Enhanced Internet.

Sander Barens, Chief Product Officer for Expereo, commented: “Unpredictable network performance may not seem, at first, like an urgent threat to your business’ success. That is until you realize the increase demands and pressure it puts on IT teams, the damaging impact it has on business efficiency and hours of productivity downtime. With Cloud applications now laying the groundwork for so many modern businesses, connecting to the public internet with the best possible application user experience is the next logical step for global businesses looking to future proof their operations.

“At Expereo, we’re already using our latest AI solution, Enhanced Internet, to lift several customers into the internet age of enhanced connectivity, with very positive results and have big plans to elevate even more global enterprises into this new era of AI internet connectivity over the coming year.”

Find out more here: Enhanced Internet (expereo.com)

About Expereo

Expereo is the intelligent internet company that connects people, places and things anywhere. Solutions include Global Internet, SD-WAN/SASE, and Enhanced Internet. With an extensive global reach, Expereo is the trusted partner of 60% of Fortune 500 companies. It powers enterprise and government sites in more than 190 countries, with the ability to connect to 600,000 locations worldwide, working with over 4,000 partners to help customers improve productivity and empowering their networks and cloud services with the agility, flexibility and value of the Internet, with optimal network performance.

Expereo was acquired in Feb 2021, by Vitruvian Partners. The international growth capital and buyout firm, acquired a majority shareholding from leading European private equity firm, Seven2.

www.expereo.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240131147075/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release

In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release

IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye